This announcement is a separate document:
复旦张江自愿披露关于盐酸氨酮戊酸口服溶液用粉末用于脑胶质瘤手术可视化验证性临床试验完成首例受试者入组的公告
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. voluntarily disclosed the completion of the first subject's enrollment in the Verification Clinical Trial of Oral Amantadine Hydrochloride Powder for Visualizing Glioma Surgery.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.